IGMS — IGM Biosciences Balance Sheet
0.000.00%
Last trade - 00:00
- $423.26m
- $85.59m
- $2.13m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 225 | 366 | 230 | 427 | 338 |
Net Total Receivables | 0.035 | — | — | — | — |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 231 | 373 | 241 | 438 | 348 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 18 | 34.8 | 56.3 | 73.1 | 74 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 261 | 409 | 298 | 513 | 423 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 8.88 | 17.2 | 27.8 | 44.7 | 42.5 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 21.1 | 26.8 | 53.2 | 226 | 220 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 240 | 382 | 245 | 287 | 203 |
Total Liabilities & Shareholders' Equity | 261 | 409 | 298 | 513 | 423 |
Total Common Shares Outstanding |